1. Mundipharma Co. Ltd. Remimazolam besylate (Anerem): Japanese prescribing information. 2020. https://www.pmda.go.jp/. Accessed 2 Mar 2020.
2. Cosmo Pharmaceuticals. Cosmo sub-licenses its ByFavo™ (remimazolam) US rights to Acacia Pharma, takes an initial 14.1% stake and provides finance for Acacia Pharma’s US expansion [media release]. 10 Jan 2020. https://www.cosmopharma.com/.
3. PAION AG. About remimazolam. 2020. https://www.paion.com/remimazolam/indikationen/leitsubstanz-remimazolam/. Accessed 2 Mar 2020.
4. PAION AG. PAION AG: Mundipharma receives market approval for Anerem® (remimazolam) in general anesthesia in Japan [media release]. 23 Jan 2020. https://www.paion.com/.
5. PAION AG. PAION announces submission of new drug application for remimazolam by its licensee Hana Pharm in South Korea [media release]. 30 Dec 2019. https://www.paion.com/.